News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abiomed (ABMD) Announces Symphony, an Implantable Synchronized Heart Pump Designed for Chronic Heart Failure Patients, at American Heart Association 2011



11/14/2011 10:53:17 AM

DANVERS, Mass.--(BUSINESS WIRE)-- Abiomed Inc. (NASDAQ: ABMD - News), a leading provider of breakthrough heart support technologies, today announced Symphony™, a new synchronized minimally invasive implantable cardiac assist device, designed to treat chronic patients with moderate heart failure by improving patient hemodynamics, and potentially improving quality of life. The device is designed with the primary goal of stabilizing the progression of heart failure and/or recovering/remodeling the heart. Prior to this, no current implantable cardiac assist device had been designed for heart recovery or remodeling.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES